Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Research article

Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

Many countries, such as Niger, are considering changing their vaccine vial size presentation and may want to evaluate the subsequent impact on their supply chains, the series of steps required to get vaccines from their manufacturers to patients. The measles vaccine is particularly important in Niger, a country prone to measles outbreaks.

Methods

We developed a detailed discrete event simulation model of the vaccine supply chain representing every vaccine, storage location, refrigerator, freezer, and transport device (e.g., cold trucks, 4 × 4 trucks, and vaccine carriers) in the Niger Expanded Programme on Immunization (EPI). Experiments simulated the impact of replacing the 10-dose measles vial size with 5-dose, 2-dose and 1-dose vial sizes.

Results

Switching from the 10-dose to the 5-dose, 2-dose and 1-dose vial sizes decreased the average availability of EPI vaccines for arriving patients from 83% to 82%, 81% and 78%, respectively for a 100% target population size. The switches also changed transport vehicle's utilization from a mean of 58% (range: 4-164%) to means of 59% (range: 4-164%), 62% (range: 4-175%), and 67% (range: 5-192%), respectively, between the regional and district stores, and from a mean of 160% (range: 83-300%) to means of 161% (range: 82-322%), 175% (range: 78-344%), and 198% (range: 88-402%), respectively, between the district to integrated health centres (IHC). The switch also changed district level storage utilization from a mean of 65% to means of 64%, 66% and 68% (range for all scenarios: 3-100%). Finally, accounting for vaccine administration, wastage, and disposal, replacing the 10-dose vial with the 5 or 1-dose vials would increase the cost per immunized patient from $0.47US to $0.71US and $1.26US, respectively.

Conclusions

The switch from the 10-dose measles vaccines to smaller vial sizes could overwhelm the capacities of many storage facilities and transport vehicles as well as increase the cost per vaccinated child.
Appendix
Available only for authorised users
Literature
1.
Clements CJ, Wesselingh SL: Vaccine presentations and delivery technologies - what does the future hold?. Expert Review of Vaccines. 1993, 4 (3): 281-287.CrossRef
2.
Drain PK, Nelson CM, Lloyd JS: Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries. Bulletin of the World Health Organization. 2003, 81 (10): 726-731.PubMedPubMedCentral
3.
PATH: Vaccines in Uniject. Technology Solutions for Global Health. 2010, Seattle: PATH
4.
Lee BY, Burke DS: Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles. Vaccine. 2010, 28 (16): 2806-2809. 10.1016/j.vaccine.2009.09.047.CrossRefPubMed
5.
Nandy R, Handzel T, Zaneidou M, Biey J, Coddy RZ, Perry R, Strebel P, Cairns L: Case-fatality rate during a measles outbreak in Eastern Niger in 2003. Clinical Infectious Diseases. 2006, 42: 322-328. 10.1086/499240.CrossRefPubMed
6.
Grais RF, Dubray C, Gerstl S, Guthmann JP, Djibo A, Nargaye KD, Coker J, Alberti KP, Cochet A, Ihekweazu C, et al: Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad. PLos Medicine. 2007, 4 (1): 122-129.CrossRef
7.
8.
9.
10.
WHO: Workshop on the deployment of a pandemic influenza vaccine: Guidelines for the deployment of a pandemic influenza vaccine. 2009, Manila, Philippines: WHO
11.
WHO: WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions. Department of Vaccines and Biologicals. 2000, Geneva: World Health Organization
12.
13.
14.
15.
PATH: Medical Waste Management for Primary Health Centers in Indonesia. 2005, Seattle: PATH
16.
Lee BY, Norman BA, Assi TM, Chen SI, Bailey RR, Rajgopal J, Brown ST, Wiringa AE, Burke DS: Single versus multi-dose vaccine vials: an economic computational model. Vaccine. 2010, 28 (32): 5292-5300. 10.1016/j.vaccine.2010.05.048.CrossRefPubMedPubMedCentral
17.
Gold MR: Cost-effectiveness in health and medicine. 1996, New York: Oxford University Press
18.
UNICEF: Vaccine Wastage Assessment. National Rural Health Mission. 2010
19.
20.
Lee JH, Kim CO: Multi-agent systems applications in manufacturing systems and supply chain management: a review paper. 2008, London, Royaume-Uni: Taylor & Francis;, 46:
21.
Klingberg J, Danielsson H, Simpson D, Pleijel H: Comparison of modelled and measured ozone concentrations and meteorology for a site in south-west Sweden: implications for ozone uptake calculations. Environ Pollut. 2008, 155 (1): 99-111. 10.1016/j.envpol.2007.10.029.CrossRefPubMed
22.
Borndorfer R, Lobel A, Weider S: A bundle method for integrated multi-depot vehicle and duty scheduling in public transit. Computer-aided Systems in Public Transport. 2008, 600 (Part 1): 3-21.CrossRef
23.
Moormann D, Mosterman JP, Looye G: Object-oriented computational model building of aircraft flight dynamics and systems. 1999, Paris, FRANCE: Elsevier
24.
Fouque JP, Papanicolaou G, Sircar K: Financial Modeling in a Fast Mean-Reverting Stochastic Volatility Environment. Asia-Pacific Financial Markets. 1999, 6 (1): 37-48. 10.1023/A:1010010626460.CrossRef
25.
Neptune RR: Computer modeling and simulation of human movement. Applications in sport and rehabilitation. Phys Med Rehabil Clin N Am. 2000, 11 (2): 417-434. viiiPubMed
26.
Trochim WM, Cabrera DA, Milstein B, Gallagher RS, Leischow SJ: Practical challenges of systems thinking and modeling in public health. Am J Public Health. 2006, 96 (3): 538-546. 10.2105/AJPH.2005.066001.CrossRefPubMedPubMedCentral
27.
Leischow SJ, Milstein B: Systems thinking and modeling for public health practice. Am J Public Health. 2006, 96 (3): 403-405. 10.2105/AJPH.2005.082842.CrossRefPubMedPubMedCentral
28.
Epstein JM: Generative social science: Studies in agent-based computational modeling. 2006, Princeton, NJ: Princeton University Press
29.
Cooley P, Lee BY, Brown S, Cajka J, Chasteen B, Ganapathi L, Stark JH, Wheaton WD, Wagener DK, Burke DS: Protecting health care workers: a pandemic simulation based on Allegheny County. Influenza Other Respi Viruses. 2010, 4 (2): 61-72. 10.1111/j.1750-2659.2009.00122.x.CrossRefPubMedCentral
30.
Lee BY, Brown ST, Cooley P, Grefenstette JJ, Zimmerman RK, Zimmer SM, Potter MA, Rosenfeld R, Wheaton WD, Wiringa AE, et al: Vaccination deep into a pandemic wave potential mechanisms for a "third wave" and the impact of vaccination. Am J Prev Med. 2010, 39 (5): e21-29. 10.1016/j.amepre.2010.07.014.CrossRefPubMedPubMedCentral
31.
Lee BY, Brown ST, Cooley P, Potter MA, Wheaton WD, Voorhees RE, Stebbins S, Grefenstette JJ, Zimmer SM, Zimmerman RK, et al: Simulating school closure strategies to mitigate an influenza epidemic. J Public Health Manag Pract. 2010, 16 (3): 252-261.CrossRefPubMedPubMedCentral
32.
Lee BY, Brown ST, Cooley PC, Zimmerman RK, Wheaton WD, Zimmer SM, Grefenstette JJ, Assi TM, Furphy TJ, Wagener DK, et al: A computer simulation of employee vaccination to mitigate an influenza epidemic. Am J Prev Med. 2010, 38 (3): 247-257. 10.1016/j.amepre.2009.11.009.CrossRefPubMed
33.
Lee BY, Brown ST, Korch GW, Cooley PC, Zimmerman RK, Wheaton WD, Zimmer SM, Grefenstette JJ, Bailey RR, Assi TM, et al: A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic. Vaccine. 2010, 28 (31): 4875-4879. 10.1016/j.vaccine.2010.05.002.CrossRefPubMedPubMedCentral
34.
Lee BY, Biggerstaff BJ: Screening the United States blood supply for West Nile Virus: a question of blood, dollars, and sense. PLoS Med. 2006, 3 (2): e99-10.1371/journal.pmed.0030099.CrossRefPubMedPubMedCentral
35.
Lee BY: Digital decision making: computer models and antibiotic prescribing in the twenty-first century. Clin Infect Dis. 2008, 46 (8): 1139-1141. 10.1086/529441.CrossRefPubMed
Metadata
Title
Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model
Publication date
01-12-2011
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-425

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue

Research article

Patterns, trends and sex differences in HIV/AIDS reported mortality in Latin American countries: 1996-2007

Study protocol

Health-promoting behaviors and social support of women of reproductive age, and strategies for advancing their health: Protocol for a mixed methods study

Research article

Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial

Research article

Evaluation of the seroprevalence of influenza A(H1N1) 2009 on a university campus: a cross-sectional study

Research article

The burden of diabetes mortality in Finland 1988-2007 - A brief report

Research article

Adolescents' perceptions about smokers in Karnataka, India